CD44 and ovarian carcinoma: CD44 or CD44v6 expression has been shown to be correlated with poor overall survival (OS) in gastric cancer (19), but CD44 or CD44v6 expression has been found to not be correlated with OS in ovarian cancer (20); these findings suggest that some prognostic information regarding CD44 is still conflicting.